Emerging treatments
Statins
One randomised controlled trial found that adding simvastatin to standard therapy was associated with survival benefits for patients with Child-Pugh class A or B cirrhosis; however, it did not reduce the risk of rebleeding. Further research is required.[80]
Use of this content is subject to our disclaimer